Clinical Trials Logo

Clinical Trial Summary

Cochlear implants are surgically implanted devices which restore the ability to hear to the hearing impaired. Recent literature has indicated that children receiving cochlear implants (CIs) often have dramatically improved speech and language ability relative to previous generations of children with hearing loss; however, many pediatric CI recipients display persistent speech and language disorders despite early implantation and associated speech/language intervention. Cochlear implants are programmed via mapping - a process in which each individual electrode (FDA approved cochlear implants have between 12 and 22 electrodes) is turned on and the stimulus level adjusted to a level that is comfortable and beneficial to the recipient. At present, this standard of care (SOC) mapping procedure is performed without knowledge of the physical location between the cochlear implant electrodes and the neural interface. Our team has developed a new method of mapping using post-operative CT scans and image processing to specify the physical relationship between the cochlear implant electrodes and the neural interface allowing customized mapping. Using this information, the investigators deactivate sub-optimally positioned electrodes. The investigators term this "Image-guided Cochlear Implant Programming" (IGCIP). This project provides a unique opportunity to examine whether individualized, image-guided CI programming (IGCIP) significantly improves outcomes in pediatric CI patients.


Clinical Trial Description

Although children with cochlear implants (CIs) have significantly improved speech, language, and reading outcomes relative to previous generation CI recipients, too many pediatric CI users still display persistent speech, language, and reading difficulties despite early implantation and early intervention. Children with CIs typically lag behind their peers with normal hearing (NH) by 1 or more years on measures of speech, language and/or reading. Though these persistent delays can be attributed in part to a period of auditory deprivation prior to implantation, increasing evidence suggests that a degraded CI signal is also implicated in poorer development of auditory, speech, language, and reading skills for pediatric CI recipients. A related developmental path to reading also disrupted from the degraded CI signal is phonological awareness (PA) because PA is predicated, in part, on speech recognition. A procedure developed by Noble and colleagues, image-guided CI programming (IGCIP), significantly improves auditory function, speech recognition, and distally, receptive language abilities for adult CI users. The investigators have preliminary evidence that pediatric CI recipients also significantly benefit from IGCIP. But there is a need to systematically investigate IGCIP in children to determine whether this individualized intervention yields a) associated benefits in auditory function and b) related improvements in speech, language, PA and/or reading. Thus, our primary goal is to evaluate the effects of IGCIP on auditory function, speech recognition, PA and reading, as well as speech and language abilities in pediatric CI recipients within the context of a double blind, waitlist controlled randomized clinical trial (RCT). The investigators will obtain psychophysical estimates of auditory function and speech recognition, PA, reading, speech, and language abilities for 72 pediatric CI users in a baseline assessment and repeated time points for 24 months to test the impact of IGCIP. The investigators will examine the immediate (short-term) and longer-term effects over a 2-year period by comparing outcomes between groups for those randomly assigned to immediate (n = 36) or deferred (n = 36) IGCIP using a waitlist control study design (deferred IGCIP). The initial comparison will be for immediate and deferred IGCIP groups at 2, 6, and 12 months. The deferred group will then receive the IGCIP intervention and both groups will be followed for an additional 12 months (total enrollment for 24 months). The proposed research includes the following aims and specific hypotheses: Aim 1: Auditory function. The investigators will compare auditory function and speech recognition of the immediate and waitlist control participants. Hypothesis 1a: There will be significant positive short-term gains (2-6 months) in spectral and/or temporal resolution as well as speech recognition-particularly in noise-for children immediately receiving IGCIP as compared to waitlist controls. This hypothesis will be tested by comparing the difference in the amount of change in scores within-subjects (pre- to post-IGCIP gain) between the groups (treated vs. untreated) controlling for initial scores. Hypothesis 1b: IGCIP gain in spectral and/or temporal resolution will significantly predict gain in speech recognition. This hypothesis will be tested via regression analyses of change in speech recognition scores on change in resolution, controlling for baseline values and also controlling for baseline levels of speech recognition and working memory. Aim 2: PA and reading. The investigators will explore the complex relationships amongst auditory function, speech recognition, PA, and reading ability. Hypothesis 2a: Differential growth in spectral/temporal resolution and/or speech recognition will predict growth in PA, which in turn will predict mediated growth in reading. Hypothesis 2b: Growth in PA will be associated with amount of IGCIP benefit (gain) and will mediate growth in reading, which will be tested via cross-legged panel and path analyses. Note that testing these hypotheses is not dependent on the outcomes of Aim 1 as only variable gain in the Aim 1 measures (e.g., speech recognition) are required for aim 2 analyses, not a significant between-group difference for IGCIP in Aim 1. Aim 3: Speech and language. The investigators will compare pre- and post-IGCIP receptive and expressive language abilities and speech production of pediatric CI recipients to the waitlist control group. The investigators will test these skills at various time points on standardized and clinical measures of 1) receptive language, 2) expressive language, and 3) speech production (articulation and acoustic analyses). Hypothesis 3a: There will be significant differences between groups for positive growth in speech and language and this growth will be predicted by the relative improvement in auditory function (aim 1) from IGCIP while controlling for baseline levels of working memory. Hypothesis 3b: Spectral/temporal resolution and speech recognition and/or PA will serve as mediators of expressive and receptive language gains and speech production gains both within and between groups. 3a and 3b will also be tested using mixed effects modeling and regression analyses to examine these "downstream" effects. Even if no between group differences in Aim 1 and/or Aim 2 are seen, the investigators will nonetheless be able to test whether spectral/temporal resolution, speech recognition, and/or PA predict growth in receptive and/or expressive language and/or changes in speech production (including subclinical acoustic analyses). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03886168
Study type Interventional
Source Vanderbilt University Medical Center
Contact Linsey Sunderhaus, AuD
Phone 615-936-7066
Email linsey.sunderhaus@vumc.org
Status Recruiting
Phase N/A
Start date June 30, 2019
Completion date March 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT04222296 - Bimodal, CROS and Severe Profound Hearing Loss Study N/A
Completed NCT04577118 - The iotaSOFT Insertion System Safety Study N/A
Withdrawn NCT04041596 - Degree of Benefit From Low-Frequency Acoustic Amplification Using the Advanced Bionics Acoustic Earhook Phase 4
Completed NCT01737489 - Title: "Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods" N/A
Completed NCT03304106 - Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population N/A
Active, not recruiting NCT03685461 - AB-Intra- and Post-Operative Measures of Auditory Function N/A
Completed NCT03515473 - Subjective and Objective Results With CI Electrode Types
Terminated NCT03025386 - Establish a Concordance Between the Mismatch Negativity Amplitude and a Score of Logatoms Discrimination N/A
Completed NCT02966379 - Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor N/A
Not yet recruiting NCT05275712 - Outcome of Cochlear Implant in Assiut University
Completed NCT03202797 - Optimizing Regulation of a Cochlear Implant in Patients With Functional Contralateral Audition.
Recruiting NCT05360212 - Anatomy-based Fitting in Cochear Implant Users N/A
Not yet recruiting NCT06142682 - Dexamethasone Eluting Cochlear Implant: a Pivotal Study N/A
Enrolling by invitation NCT03306082 - Image-guided Cochlear Implant Programming (IGCIP) N/A
Enrolling by invitation NCT04320251 - Tissue Growth Characterization for Cochlear Implant Users N/A
Recruiting NCT05079867 - Cochlear Trauma, Functional and Structural Preservation in Cochlear Implant Surgery
Recruiting NCT06086041 - Predictive Study on Hearing Rehabilitation After Cochlear Implant
Active, not recruiting NCT04722042 - Place-based Mapping in EAS Listeners N/A
Recruiting NCT04711538 - Role of Diagnostic Imaging in Cochlear Implant
Completed NCT01638052 - Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery Phase 2